AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30025177
Drug: 9 g
RxNorm normalized name: Publix Pen Needle 29 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g of intravenous MgSO4 (high-dose group)
Trial: 30025177
Drug: Serum saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum saline infusion (placebo group)
Trial: 24848793
Drug: Synbiotic capsules
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic capsules containing 200 million of seven strains of friendly bacteria plus fructo‐oligosaccharide, twice a day for 28 weeks
Trial: 24848793
Drug: Placebo capsules,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules, twice a day for 28 weeks
Trial: 19084376
Drug: Enriched milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enriched milk (500 mL/d)
Trial: 19084376
Drug: Skimmed milk
RxNorm normalized name: Calcium fortified skimmed milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skimmed milk (500 mL/d)
Trial: 19084376
Drug: Semi-skimmed milk
RxNorm normalized name: Calcium fortified semi-skimmed milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semi-skimmed milk (500 mL/d)
Trial: 11990912
Drug: Single 400-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 400-mg fluconazole dose
Trial: 9226511
Drug: Dexamethasone 0.5
RxNorm normalized name: dexamethasone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.5 mg administered nightly with gonadotropin therapy
Trial: 9226511
Drug: Gonadotropin therapy
RxNorm normalized name: Chorionic Gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotropin therapy without dexamethasone (control group)
Trial: 2890509
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg (three times)
Trial: 28043163
Drug: Medication Adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication Adherence Report Scale (MARS)
Trial: 30027281
Drug: IPC +
RxNorm normalized name: CAP,IPC VALVE ROCKET #54410
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPC + low-molecular-weight (LMW) heparin sodium
Trial: 30027281
Drug: IPC +
RxNorm normalized name: CAP,IPC VALVE ROCKET #54410
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPC + LMW heparin sodium
Trial: 15956124
Drug: Tecadenoson (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tecadenoson (various doses)
Trial: 10878628
Drug: iodixanol (Visipaque)
RxNorm normalized name: Iodixanol
DrugBank: Iodixanol (DB01249)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iodixanol (Visipaque) 320 mg I/ml
Trial: 10878628
Drug: iohexol (Omnipaque)
RxNorm normalized name: Iohexol
DrugBank: Iohexol (DB01362)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iohexol (Omnipaque) 350 mg I/ml
Trial: 9426846
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin D3 (Calcijex and injectable One‐Alpha)
Trial: 9426846
Drug: Oral One‐Alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral One‐Alpha
Trial: 3886399
Drug: BAY l
RxNorm normalized name: Bay Leaf
DrugBank: Laurus nobilis (DB10670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY l 5240 (nifedipine 10 mg + acebutolol 100 mg)
Trial: 2465650
Drug: Intra-arterial chemotherapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial chemotherapy with methotrexate (MTX) and 5-fluorouracil (5FU)
Trial: 2465650
Drug: Intra-venous CMFV
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-venous CMFV treatment (in cases with objective remission)
Trial: 2465650
Drug: Systemic FACV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic FACV combination
Trial: 28340118
Drug: Group Music
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Music Therapy (GMT)
Trial: 26270586
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg IV dexamethasone
Trial: 24086815
Drug: Silver zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver zinc sulfadiazine cream (AgZnSD)
Trial: 19892663
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) at 500 mg/m(2)
Trial: 19892663
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) at 750 mg/m(2)
Trial: 19892663
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) at 1,000 mg/m(2)
Trial: 15538094
Drug: losartan/hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan/hydrochlorothiazide (50 mg/12.5 mg)
Trial: 2430180
Drug: Oral tetrahydroaminoacridine
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tetrahydroaminoacridine (THA)
Trial: 30500141
Drug: Dapsone gel,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone gel, 7.5%
Trial: 25008127
Drug: Web-based guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based guided self-help intervention (Happy@Work), consisting of 6 lessons of problem-solving treatment and cognitive therapy, with weekly assignments and feedback from a coach.
Trial: 20688462
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg of rhTSH IV 24 h before (123)I
Trial: 20688462
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg of rhTSH IV 48 h before (123)I
Trial: 18279973
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) session
Trial: 10322096
Drug: Alpha1-proteinase inhibitor
RxNorm normalized name: Alpha1-proteinase inhibitor
DrugBank: Alpha-1-proteinase inhibitor (DB00058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha1-proteinase inhibitor therapy (four intravenous doses)
Trial: 7497557
Drug: Mivacurium 2
RxNorm normalized name: mivacurium 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 2 x ED95 (0.150 mg.kg‐1) with priming
Trial: 7497557
Drug: Mivacurium 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 3 x ED95 (0.215 mg.kg‐1) with priming
Trial: 8042808
Drug: Succinylcholine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine (1 mg.kg‐1)
Trial: 7497557
Drug: Mivacurium 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 1 x ED95 (0.075 mg.kg‐1) with priming
Trial: 2742729
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg d-amphetamine
Trial: 12066946
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg mifepristone as a single dose
Trial: 12066946
Drug: Yuzpe regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yuzpe regimen (two tablets each with 50 microg ethinyloestradiol and 0.25 mg levonorgestrel, repeated 12 hours later)
Trial: 7649072
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg daily for 6 weeks
Trial: 2678424
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg three times daily)
Trial: 26974214
Drug: Risperidone long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone long-acting injectable 50 mg
Trial: 26974214
Drug: Risperidone long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone long-acting injectable 25 mg
Trial: 22370535
Drug: Pranlukast dry
RxNorm normalized name: pranlukast
DrugBank: Pranlukast (DB01411)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Pranlukast dry syrup (PLK DS)
Trial: 18681749
Drug: Risperidone (0.25-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (0.25-2 mg/day)
Trial: 9043896
Drug: 150 IU
RxNorm normalized name: Follitropin Beta 150 IU/0.5 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 IU FSH administered to husbands, either i.m. or s.c., three times a week, starting 3 months before IUI cycles and maintained until the fifth IUI cycle
Trial: 9043896
Drug: 150 IU
RxNorm normalized name: Follitropin Beta 150 IU/0.5 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 IU FSH administered to husbands
Trial: 3358881
Drug: Pindolol 5
RxNorm normalized name: pindolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 5 mg three times daily
Trial: 6111212
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg daily
Trial: 29088928
Drug: Lithium (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (target serum concentration, 0.80-0.99 mEq/L)
Trial: 29088928
Drug: Divalproex (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divalproex (target serum valproate concentration, 80-99 μg/mL)
Trial: 18007568
Drug: Adjunctive risperidone
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adjunctive risperidone
Trial: 25103148
Drug: Imiquimod, 5%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod, 5%, cream (44 patients)
Trial: 25103148
Drug: Intralesional Mycobacterium
RxNorm normalized name: Mycobacterium phlei
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional Mycobacterium w (Mw) vaccine (45 patients)
Trial: 19170911
Drug: Magnetocardiography (MCG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetocardiography (MCG) after electrical cardioversion (CV)
Trial: 19170911
Drug: Magnetocardiography (MCG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetocardiography (MCG) after 1 month in SR
Trial: 17586422
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (PUFAs) 1.7 g
Trial: 18436564
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (olive oil)
Trial: 14513268
Drug: Alfacalcidol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol (1 microg) plus calcium (500 mg)
Trial: 14513268
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (1000 IU) plus calcium (500 mg)
Trial: 11688520
Drug: Gemcitabine (G)
DrugBank: Gemcitabine (DB00441)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Gemcitabine (G) plus Epirubicin (E) plus Taxol (T) (GET)
Trial: 11688520
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose chemotherapy (HDCT) after GET
Trial: 8851643
Drug: Midday light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midday light therapy
Trial: 8851643
Drug: Morning light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning light therapy
Trial: 8851643
Drug: Evening light
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening light therapy
Trial: 8851643
Drug: Light treatment
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light treatment (general)
Trial: 540522
Drug: 0.05% clobetasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% clobetasone butyrate cream
Trial: 21926601
Drug: Hydrocortisone 200
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone 200 mg/day (HC group)
Trial: 19036894
Drug: PRO-CHO (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRO-CHO (1.2 g CHO + 0.4 g protein x kg(‐1) x h(‐1))
Trial: 19036894
Drug: L-CHO (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-CHO (1.2 g CHO x kg(‐1) x h(‐1))
Trial: 19036894
Drug: H-CHO (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-CHO (1.6 g CHO x kg(‐1) x h(‐1))
Trial: 19036894
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g CHO x kg(‐1) x h(‐1)
Trial: 17434014
Drug: Quin-Lng (levonorgestrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quin-Lng (levonorgestrel 6 mg)
Trial: 17434014
Drug: Quin-Ng (quinestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quin-Ng (quinestrol 3 mg and norgestrel 12 mg)
Trial: 11307656
Drug: Tramadol (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1.5 mg.kg‐1)
Trial: 15352967
Drug: Propacetamol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propacetamol (2 g)
Trial: 9720832
Drug: Nafarelin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin (200 microg intranasal, twice a day for 6 months)
Trial: 30954360
Drug: Intravenous phenobarbital
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous phenobarbital (PB) at 10 mg/kg
Trial: 30954360
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 ml of normal saline)
Trial: 30954360
Drug: Intravenous phenobarbital
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous phenobarbital (PB) at 10 mg/kg (after placebo failure)
Trial: 19366489
Drug: Aripiprazole (partial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (partial agonist)
Trial: 19366489
Drug: Antagonist antipsychotics
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Antagonist antipsychotics (risperidone or olanzapine)
Trial: 16955110
Drug: Cefotaxime/heparin lock
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime/heparin lock (group I)
Trial: 11211363
Drug: MTA behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTA behavioral and medication treatments
Trial: 11211363
Drug: MTA medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTA medication treatments (with or without behavioral treatments)
Trial: 11211363
Drug: Combined (medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined (medication and behavioral) treatments
Trial: 2899236
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg acetylsalicylic acid (ASA) orally starting 12 h after admission and then intermittently every third day for one month
Trial: 9431267
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg acetylsalicylic acid (ASA)
Trial: 30922297
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg orally once daily for 6 weeks
Trial: 19661078
Drug: CARET intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CARET intervention (30 mg beta-carotene + 25,000 IU retinyl palmitate) with additional supplements
Trial: 19661078
Drug: Postintervention phase
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postintervention phase (CARET + other supplements)
Trial: 19661078
Drug: CARET intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CARET intervention (30 mg beta-carotene + 25,000 IU retinyl palmitate)
Trial: 16961710
Drug: Killed Mycobacterium
RxNorm normalized name: Heat Killed Mycobacterium W Immunomodulator
DrugBank: Mycobacterium w. Vaccine (DB15798)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Killed Mycobacterium vaccae (1 mg)
Trial: 16961710
Drug: Killed Mycobacterium
RxNorm normalized name: Heat Killed Mycobacterium W Immunomodulator
DrugBank: Mycobacterium w. Vaccine (DB15798)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Killed Mycobacterium vaccae (0.1 mg)
Trial: 11197402
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide at 5 ppm
Trial: 11147718
Drug: buserelin MP
RxNorm normalized name: buserelin
DrugBank: Buserelin (DB06719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buserelin MP 1.8 mg
Trial: 11147718
Drug: leuprolide 1.88
FDA approved: no
EMA approved: no
PMDA approved: no
Description: leuprolide 1.88 mg
Trial: 3096429
Drug: Multiple insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple insulin injections (five or six daily)
Trial: 3096429
Drug: Conventional twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional twice daily insulin injections
Trial: 24918556
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg daily for 8 weeks
Trial: 24918556
Drug: Lymecycline 300
RxNorm normalized name: lymecycline 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymecycline 300 mg daily for 8 weeks
Trial: 18534327
Drug: Saw palmetto
RxNorm normalized name: Saw palmetto
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saw palmetto extract (160 mg twice daily)
Trial: 15920008
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for acute lymphoblastic leukemia (ALL)
Trial: 9893189
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone 100 microg administered twice daily for 4 weeks
Trial: 1885267
Drug: 100ml orange
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100ml orange juice with dissolved K‐ and Mg‐phosphates (K, 40mmol; Mg, 17.5mmol; HPO4, 35mmol)
Trial: 1885267
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of ephedrine intravenously, 0.25mg/kg body weight
Trial: 6395614
Drug: Metronidazole (two-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (two-dose perioperative course, rectally administered)
Trial: 6395614
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of metronidazole and T-tube suction drainage
Trial: 27112632
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% imiquimod cream applied 3 times per week for 12 weeks
Trial: 20626240
Drug: Metformin 2550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 2550 mg/day
Trial: 19056578
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose (75 g)
Trial: 12576260
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 mg per day) + Conjugated estrogen cream (0.5 g)
Trial: 12576260
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 mg per day) + Nonhormonal moisturizer
Trial: 12576260
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Conjugated estrogen cream (0.5 g)
Trial: 8723144
Drug: Remacemide hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Remacemide (DB06458)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remacemide hydrochloride 200 mg/day
Trial: 8723144
Drug: Remacemide hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Remacemide (DB06458)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remacemide hydrochloride 600 mg/day
Trial: 1653795
Drug: Nifedipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (2 x 20 mg/day)
Trial: 1653795
Drug: Hydergine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydergine (2 x 2 mg/day)
Trial: 1653795
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Nifedipine 20 mg/day and Hydergine 2 mg/day, twice daily each)
Trial: 6661351
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg/day
Trial: 2978324
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg/day
Trial: 15683500
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg/day
Trial: 28294173
Drug: UHT dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UHT dairy milk (1.5 l for 21 days)
Trial: 28294173
Drug: PAST dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAST dairy milk (1.5 l for 21 days)
Trial: 22568828
Drug: FPSM/BDP (Fluticasone/Salmeterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPSM/BDP (Fluticasone/Salmeterol + HFA-beclomethasone diproprionate 200 µg twice daily)
Trial: 22568828
Drug: FPSM/PRED (Fluticasone/Salmeterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPSM/PRED (Fluticasone/Salmeterol + Prednisolone 25 mg day(‐1) for 1 week)
Trial: 22568828
Drug: FPSM/FP (Fluticasone/Salmeterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPSM/FP (Fluticasone/Salmeterol + Fluticasone 250 µg twice daily)